U.S. Markets closed
  • S&P Futures

    4,123.00
    +5.00 (+0.12%)
     
  • Dow Futures

    33,673.00
    +49.00 (+0.15%)
     
  • Nasdaq Futures

    13,817.00
    +18.25 (+0.13%)
     
  • Russell 2000 Futures

    2,249.40
    +4.40 (+0.20%)
     
  • Crude Oil

    62.74
    -0.41 (-0.65%)
     
  • Gold

    1,738.50
    +2.20 (+0.13%)
     
  • Silver

    25.50
    -0.02 (-0.09%)
     
  • EUR/USD

    1.1988
    +0.0033 (+0.2757%)
     
  • 10-Yr Bond

    1.6380
    +0.0150 (+0.92%)
     
  • Vix

    16.99
    +0.34 (+2.04%)
     
  • GBP/USD

    1.3782
    +0.0030 (+0.2178%)
     
  • USD/JPY

    108.8520
    -0.1960 (-0.1797%)
     
  • BTC-USD

    63,258.75
    -79.37 (-0.13%)
     
  • CMC Crypto 200

    1,374.67
    -1.11 (-0.08%)
     
  • FTSE 100

    6,939.58
    +49.09 (+0.71%)
     
  • Nikkei 225

    29,684.71
    +63.72 (+0.22%)
     

Certara to Present at the Barclays Global Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William Feehery, CEO and Andrew Schemick, CFO will virtually present at the Barclays Global Healthcare Conference on Tuesday, March 9, 2021 at 11:30 a.m. ET.

A live webcast will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for 90 days thereafter.

About Certara

Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210226005476/en/

Contacts

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Elizabeth Tang, Ph.D.
Finn Partners
elizabeth.tang@finnpartners.com